Lord Berkeley Alert Sample


Alert Sample

View the Parallel Parliament page for Lord Berkeley

Information between 17th April 2026 - 27th May 2026

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Calendar
Monday 22nd June 2026 2:30 p.m.
Lord Berkeley (Labour - Life peer)

Oral questions - Main Chamber
Subject: HS2 Limited payments to consultants in the last year
View calendar - Add to calendar


Division Votes
20 Apr 2026 - Children’s Wellbeing and Schools Bill - View Vote Context
Lord Berkeley voted No - in line with the party majority and against the House
One of 156 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 276 Noes - 169
20 Apr 2026 - Pension Schemes Bill - View Vote Context
Lord Berkeley voted No - in line with the party majority and against the House
One of 138 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 219 Noes - 144
20 Apr 2026 - Children’s Wellbeing and Schools Bill - View Vote Context
Lord Berkeley voted No - in line with the party majority and against the House
One of 147 Labour No votes vs 4 Labour Aye votes
Tally: Ayes - 284 Noes - 158
20 Apr 2026 - Pension Schemes Bill - View Vote Context
Lord Berkeley voted No - in line with the party majority and against the House
One of 142 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 211 Noes - 150
20 Apr 2026 - Pension Schemes Bill - View Vote Context
Lord Berkeley voted No - in line with the party majority and against the House
One of 141 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 216 Noes - 148
20 Apr 2026 - Children’s Wellbeing and Schools Bill - View Vote Context
Lord Berkeley voted No - in line with the party majority and against the House
One of 153 Labour No votes vs 1 Labour Aye votes
Tally: Ayes - 259 Noes - 180
28 Apr 2026 - Children’s Wellbeing and Schools Bill - View Vote Context
Lord Berkeley voted No - in line with the party majority and in line with the House
One of 160 Labour No votes vs 0 Labour Aye votes
Tally: Ayes - 91 Noes - 181


Speeches
Lord Berkeley speeches from: King’s Speech
Lord Berkeley contributed 1 speech (678 words)
Wednesday 20th May 2026 - Lords Chamber
Department for Transport
Lord Berkeley speeches from: Rail Safety Recommendations: Backlog
Lord Berkeley contributed 1 speech (70 words)
Tuesday 28th April 2026 - Lords Chamber
Lord Berkeley speeches from: Clean Power 2030 Action Plan: Rural Communities
Lord Berkeley contributed 1 speech (605 words)
Wednesday 22nd April 2026 - Lords Chamber
Department for Energy Security & Net Zero
Lord Berkeley speeches from: Trains: Punctuality
Lord Berkeley contributed 1 speech (89 words)
Monday 20th April 2026 - Lords Chamber
Department for Transport


Written Answers
High Speed 2 Line: Construction
Asked by: Lord Berkeley (Labour - Life peer)
Wednesday 22nd April 2026

Question to the Department for Transport:

To ask His Majesty's Government what assessment they have made of the timetable for completion of the High Speed Rail Phase 2b to take traffic.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

The government is taking forward the High Speed Rail (Crewe – Manchester) Bill to deliver the Northern Powerhouse Rail route into Manchester via Manchester Airport. We have not reversed the previous government’s decision to cancel HS2 Phase 2 and will adapt the bill to deliver only the section of route necessary for Northern Powerhouse Rail.

In light of lessons from HS2, we are carefully developing detailed plans for delivery. However, from our work to date, we expect major construction works for the Liverpool to Manchester section of the route to commence in the mid-2030s and continue into the 2040s.

Low Traffic Neighbourhoods
Asked by: Lord Berkeley (Labour - Life peer)
Monday 27th April 2026

Question to the Department for Transport:

To ask His Majesty's Government whether the statutory guidance Implementing low traffic neighbourhoods, published on 17 March 2024, is current government policy.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

The guidance was published in draft in March 2024 but never brought into force. The Government is considering next steps and more information will be made available in due course.

As is longstanding policy, local authorities are best placed to decide what traffic management schemes are appropriate, including low-traffic neighbourhoods, but they should always be developed through engagement with local communities.

High Speed 2 Line: Construction
Asked by: Lord Berkeley (Labour - Life peer)
Monday 27th April 2026

Question to the Department for Transport:

To ask His Majesty's Government, pursuant to the HS2 Project Update, published on 25 March, which states “We must slow or pause some work while other sites catch up. This includes … secondary work supporting London’s tunnel network” and “We’ve deferred some works outside this area, including … secondary works on the London tunnels network”, what is the scope of that secondary work.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

HS2 Ltd has extended the deferral of works between Birmingham and Handsacre, in place since spring 2023, to focus efforts on the cost-efficient delivery of the opening stage of HS2 between Old Oak Common and Birmingham Curzon Street. The scope of secondary works on the tunnels include construction activity relating to tunnel vent shafts, headhouses and walkways.

High Speed 2 Line: Crewe
Asked by: Lord Berkeley (Labour - Life peer)
Tuesday 28th April 2026

Question to the Department for Transport:

To ask His Majesty's Government whether they intend to publish any further reports, previously commissioned by HS2 Ltd, on the risk of settlement of areas around Crewe.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

This report https://www.gov.uk/government/publications/hs2-phase-2b-select-committee-crewe-to-manchester-understanding-the-ground-risk-across-the-cheshire-plain was commissioned and published as a comprehensive report into the ground risk north of Crewe across the Cheshire plain.

The Government does not expect to publish any further information.

High Speed 2 Line
Asked by: Lord Berkeley (Labour - Life peer)
Tuesday 28th April 2026

Question to the Department for Transport:

To ask His Majesty's Government who will be the promoter of the Crewe to Manchester section of High Speed Rail; and whether they intend to let contracts on a cost-plus basis in a similar way to those let for Phase 1.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

HS2 Ltd continue to support the promotion of the High Speed Rail (Crewe-Manchester) Bill which will be adapted to deliver only the section of route necessary for Northern Powerhouse Rail. No decisions have been taken on the long-term delivery strategy on contracting choices for the Northern Powerhouse Rail programme at this stage.

Our long-term ambition is to improve capacity and connectivity between Birmingham and Manchester with a new rail line. This will not be a reinstatement of HS2 and no decisions have been taken on the exact specification, route or the approach to implementing or contracting the project.

We will learn lessons from the implementation of HS2 to take the time necessary to undertake the development work to underpin these decisions.

High Speed 2 Line
Asked by: Lord Berkeley (Labour - Life peer)
Tuesday 28th April 2026

Question to the Department for Transport:

To ask His Majesty's Government whether the mayors of Liverpool, Manchester and areas east of the Pennines have approved the route of High Speed Rail Phase 2b.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

The government is taking forward the High Speed Rail (Crewe – Manchester) Bill to deliver the Northern Powerhouse Rail route into Manchester via Manchester Airport. We have not reversed the previous government’s decision to cancel HS2 Phase 2 and will adapt the bill to deliver only the section of route necessary for Northern Powerhouse Rail.

The Government engaged closely with Mayors across the North of England during the development of the Northern Growth Strategy. Compact agreements with each Mayoral Combined Authority show the support for the Programme and the approach and are available online within the Rail Network Correspondence section of the Government's website.

We will continue to work in close collaboration with Mayors and partners across the North throughout the development and delivery of Northern Powerhouse Rail.

High Speed 2 Line
Asked by: Lord Berkeley (Labour - Life peer)
Tuesday 28th April 2026

Question to the Department for Transport:

To ask His Majesty's Government what assessment they have made, if any, of the proposal published by Chris Gibb, HS2 – Getting the job done… a new approach in May 2024, and (1) whether any such assessment compared capacity and journey times with HS2 Limited’s latest plans, (2) whether it outlined how they will consider forecasted demand in the 2040s, and (3) what assumptions they made on pricing and compulsory reservation strategy and their role in managing unconstrained demand.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

Aspects of the proposal have been analysed for their technical feasibility and how they would support passengers on HS2 in the long term. The Department is working with industry on potential interventions to further improve journeys for Northwest passengers when high-speed services operate on the West Coast Mainline.

In addition, the Northern Growth Strategy announcement of January 2026 set out the Government’s intention to ultimately deliver a full North-South new line between Birmingham and Manchester. This will enable the Government to safeguard future growth for the long term by ensuring the West Coast Main Line corridor offers sufficient capacity and good connectivity.

High Speed 2 Line
Asked by: Lord Berkeley (Labour - Life peer)
Tuesday 28th April 2026

Question to the Department for Transport:

To ask His Majesty's Government whether they will publish the exact High Speed Rail Phase 2b Crewe to Manchester route, and connections to other rail projects in the area.

Answered by Lord Hendy of Richmond Hill - Minister of State (Department for Transport)

The route of the original Phase 2b scheme can be found in the Online Government Collection titled: HS2 Phase 2b: Crewe to Manchester and the West Midlands to Leeds.

The government will adapt the High Speed Rail (Crewe-Manchester) Bill to deliver only the section of route necessary for Northern Powerhouse Rail. Following the Instruction Motion passed in the House of Commons in May 2024, the Bill will be truncated at a point in the vicinity of the Parish of Millington and Rostherne. The Government will set out further details when the Hybrid Bill Select Committee recommences.




Lord Berkeley mentioned

Live Transcript

Note: Cited speaker in live transcript data may not always be accurate. Check video link to confirm.

19 May 2026, 6 p.m. - House of Lords
"Berkeley has said, the noble Lord, Lord Berkeley has said of teaching music in schools. 60 years ago, at "
Lord Blackwater (Conservative) - View Video - View Transcript
19 May 2026, 6:50 p.m. - House of Lords
"Bonham-Carter said, everything Lord Berkeley said quite a lot of things, "
Lord Wigley (Plaid Cymru) - View Video - View Transcript
19 May 2026, 6:51 p.m. - House of Lords
"which Lord Berkeley did mention, which includes conservatoires, but also specialist music schools, as "
Baroness Debbonaire (Labour) - View Video - View Transcript
19 May 2026, 9:54 p.m. - House of Lords
"noble Lord Berkeley, and noble Baroness Keeley all set out that powerfully the damage done to the "
Lord Clement-Jones (Liberal Democrat) - View Video - View Transcript
20 May 2026, 9:59 p.m. - House of Lords
"The noble Lord Barclay, my noble friend Lord Berkeley, and noble "
Lord Hendy of Richmond Hill, Minister of State (Department for Transport) (Labour) - View Video - View Transcript
20 May 2026, 10 p.m. - House of Lords
"is a scandal, I'm sure, that he, noble Lord Berkeley, can be satisfied that he did tell us it would cost a lot of money. He did "
Lord Hendy of Richmond Hill, Minister of State (Department for Transport) (Labour) - View Video - View Transcript
20 May 2026, 9:29 p.m. - House of Lords
"out the remarks made by the noble Lord, Lord Berkeley, who I think "
Lord Moylan (Conservative) - View Video - View Transcript
20 May 2026, 9:38 p.m. - House of Lords
"Now both the noble Lord, Lord Berkeley, and the noble Baroness, lady Pidgeon, spoke in favour of "
Lord Moylan (Conservative) - View Video - View Transcript


Parliamentary Debates
King’s Speech
102 speeches (43,089 words)
Wednesday 20th May 2026 - Lords Chamber
Department for Transport
Mentions:
1: Lord Moylan (Con - Life peer) propose to respond to them all, but I would like to single out the remarks made by the noble Lord, Lord Berkeley - Link to Speech
2: Lord Hendy of Richmond Hill (Lab - Life peer) considerable amount of money in this spending review to move forward with them.My noble friend Lord Berkeley - Link to Speech

King’s Speech
149 speeches (53,868 words)
Tuesday 19th May 2026 - Lords Chamber
Department for Energy Security & Net Zero
Mentions:
1: Lord Blackwater (Con - Life peer) agreement: the importance of teaching music in schools, which was mentioned by the noble Lord, Lord Berkeley - Link to Speech
2: Baroness Debbonaire (Lab - Life peer) , said, everything the noble Baroness, Lady Bonham-Carter, said and everything the noble Lord, Lord Berkeley - Link to Speech
3: Lord Clement-Jones (LD - Life peer) being only a draft Bill.My noble friends Lord Strasburger and Lady Bonham- Carter, the noble Lord, Lord Berkeley - Link to Speech



Select Committee Documents
Tuesday 19th May 2026
Oral Evidence - Brainomix, and Scancell

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee

Found: and AI Tuesday 19 May 2026 11.30 am Watch the meeting Members present: Lord Mair (The Chair); Lord Berkeley

Tuesday 19th May 2026
Oral Evidence - Autolus Therapeutics, and Genomics Ltd

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee

Found: and AI Tuesday 19 May 2026 10.15 am Watch the meeting Members present: Lord Mair (The Chair); Lord Berkeley



Non-Departmental Publications - Statistics
Jul. 21 2020
Law Commission
Source Page: Leasehold home ownership: buying your freehold or extending your lease
Document: (PDF)
Statistics

Found: to manage – therefore reflects the current law in respect of both regimes.83 81 We note that Lord Berkeley




Lord Berkeley - Select Committee Information

Calendar
Tuesday 28th April 2026 10 a.m.
Science and Technology Committee - Private Meeting
View calendar - Add to calendar
Tuesday 19th May 2026 10 a.m.
Science and Technology Committee - Oral evidence
Subject: Innovation in the NHS: personalised medicine and AI
At 10:15am: Oral evidence
Dr Christian Itin - Chief Executive Officer at Autolus Therapeutics
Professor Peter Donnelly - Chief Executive Officer at Genomics Ltd
At 11:15am: Oral evidence
Dr Michalis Papadakis - Chief Executive Officer and Co-Founder at Brainomix
Dr Phil L'Huillier - Chief Executive Officer at Scancell
View calendar - Add to calendar
Tuesday 2nd June 2026 10 a.m.
Science and Technology Committee - Oral evidence
Subject: Innovation in the NHS: personalised medicine and AI
At 10:15am: Oral evidence
The Baroness Blackwood of North Oxford - Chair at Health Data Research Service (HDRS)
Dr Melanie Ivarsson - Chief Executive Officer at Health Data Research Service (HDRS)
View calendar - Add to calendar
Tuesday 9th June 2026 10 a.m.
Science and Technology Committee - Oral evidence
Subject: Innovation in the NHS: personalised medicine and AI
At 10:15am: Oral evidence
Roland Sinker CBE - Former CEO at Cambridge University Hospitals Trust (2015-2025)
At 11:15am: Oral evidence
Professor Andrew Beggs - Professor of Cancer Genetics and Surgery at University of Birmingham
Professor Mikael Sodergren - Clinical Associate Professor at Imperial College London
View calendar - Add to calendar
Tuesday 16th June 2026 10 a.m.
Science and Technology Committee - Oral evidence
Subject: Innovation in the NHS: personalised medicine and AI
At 10:15am: Oral evidence
Dr Stephen Harden - President at The Royal College of Radiologists (RCR)
Dr Bernie Croal - President at The Royal College of Pathologists
At 11:15am: Oral evidence
Dr Pritesh Mistry - Fellow, Digital Technologies at The Kings Fund
Professor Ben Bridgewater - Chief Executive Officer at Health Innovation Manchester
View calendar - Add to calendar


Select Committee Documents
Tuesday 21st April 2026
Government Response - Government response to Rebuilding Forensic Science for Criminal Justice: An urgent need

Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Queen Mary University of London, Queen Mary University of London, Queen Mary University of London, and Queen Mary University of London
PMA0035 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - The University of Manchester
PMA0036 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Association of the British Pharmaceutical Industry
PMA0034 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - National Centre for Universities and Business
PMA0033 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Genedrive Diagnostics
PMA0030 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - BSI
PMA0032 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Office of Health Economics
PMA0031 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Genomics England
PMA0021 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - The Institution of Engineering and Technology (IET)
PMA0024 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Boehringer Ingelheim
PMA0023 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - FairGo CIC
PMA0018 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Liverpool John Moores University, Liverpool John Moores University, University Hospitals Liverpool NHS Group, and University Hospitals Liverpool NHS Group
PMA0020 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - University College London, University of Strathlyde, and University of Strathclyde
PMA0019 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Royal College of Pathologists
PMA0027 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Russell Group
PMA0028 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Yorkshire Cancer Research
PMA0025 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - FairGo CIC
PMA0017 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - University of Cambridge
PMA0006 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - UK Cancer Vaccine AI Scientist and Supercomputing Project
PMA0001 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - AI & Partners
PMA0003 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Eventum orthopeadics Ltd
PMA0002 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - Kingston University London
PMA0004 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 28th April 2026
Written Evidence - PharmBot AI
PMA0005 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 21st April 2026
Oral Evidence - Our Future Health, and UK Biobank

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 21st April 2026
Oral Evidence - Professor Dame Sue Hill

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - Newton's Tree
PMA0014 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - Association of British HealthTech Industries (ABHI)
PMA0026 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - University of Birmingham
PMA0012 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - University of Turin, University of Cardiff, University of St. Andrews, University of St. Andrews, University of St. Andrews, and University of St. Andrews
PMA0015 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - Royal Holloway University of London, Royal Holloway University of London, Royal Holloway University of London, and Royal Holloway University of London
PMA0008 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - Cassandra Policy CIC
PMA0007 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - Faculty of Pharmaceutical Medicine
PMA0013 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - University of Bristol & Bangor University
PMA0011 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - University of Wolverhampton, City St George's University of London, London, U.K., University of Nottingham, Nottingham, U.K., University of Wolverhampton, University of Wolverhampton, University of Cambridge, Cambridge, U.K., and Royal Wolverhampton NHS Trust and University of Wolverhampton, Wolverhampton, UK
PMA0010 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 29th April 2026
Written Evidence - The PRICI Foundation
PMA0009 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Wellcome Sanger Institute
PMA0067 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - UCLPartners
PMA0069 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - National Physical Laboratory
PMA0068 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - MSD UK
PMA0045 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - LifeArc
PMA0053 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Brain Tumour Research
PMA0046 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Faculty of Wellbeing, Education & Languages, The Open University, STEM, The Open University, Department of Life Sciences, Manchester Metropolitan University, University “Mother Teresa” Skopje, North Macedonia, and The Hague University of Applied Sciences in the Netherlands
PMA0047 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Prostate Cancer Research
PMA0050 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - female
PMA0052 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Personalised Medicine Centre, School of Medicine, Ulster University, and Personalised Medicine Centre, School of Medicine, Ulster University
PMA0049 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Ms Vivien Thom
PMA0048 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - University of Liverpool
PMA0042 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - D Analytics Ltd
PMA0041 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - NICE (National Institute for Health and Care Excellence)
PMA0044 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - The University of Manchester
PMA0037 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Prelego Holdings Ltd
PMA0040 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Health Innovation Network (HIN) South London
PMA0038 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - University of Manchester
PMA0039 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Vitanium
PMA0016 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - UK Dementia Research Institute (UK DRI)
PMA0054 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - CPI (part of the High Value Manufacturing Catapult)
PMA0051 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Genetic Alliance UK
PMA0065 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Royal Statistical Society
PMA0064 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Heart UK
PMA0066 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Health Innovation Network
PMA0061 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Breast Cancer Now
PMA0063 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - University of Reading
PMA0062 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - University of Southampton, and University of Southampton
PMA0057 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Imperial College London
PMA0058 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - National Engineering Policy Centre
PMA0059 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Cognaris Ltd
PMA0055 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Wednesday 20th May 2026
Written Evidence - Professional Record Standards Body CiC
PMA0056 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 19th May 2026
Oral Evidence - Autolus Therapeutics, and Genomics Ltd

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 19th May 2026
Oral Evidence - Brainomix, and Scancell

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - Proven Connect
PMA0070 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - Independent Healthcare Providers Network (IHPN)
PMA0079 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - Academy of Medical Sciences
PMA0074 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - UCB
PMA0075 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - Cancer Research UK
PMA0072 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - Sense about Science
PMA0071 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - The Royal College of Surgeons of Edinburgh
PMA0073 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - National Measurement Laboratory (NML) at LGC
PMA0078 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - British In Vitro Diagnostics Association (BIVDA)
PMA0077 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Friday 22nd May 2026
Written Evidence - School of Social and Political Science, University of Edinburgh, Usher Institute, University of Edinburgh, Robinson College, University of Cambridge, Institute for the Study of Science, Technology and Innovation, University of Edinburgh, and Usher Institute, University of Edinburgh
PMA0076 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Isomorphic Labs
PMA0109 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - illumina
PMA0108 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - RAND Europe
PMA0084 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - The Royal College of Physicians
PMA0083 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Stealth Labs
PMA0085 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Keep Up With Cancer (KUWC)
PMA0117 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Lyzeum Ltd & University of Cambridge, Department of Pathology
PMA0101 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Health Data Research UK (HDR UK)
PMA0100 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Galactic Rhythm
PMA0102 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - B Braun Medical
PMA0113 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - PCD Research
PMA0105 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - 8GI Foundation
PMA0107 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Lancashire and South Cumbria Cancer Alliance (ICB)
PMA0106 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Royal College of Radiologists
PMA0080 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - techUK
PMA0081 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Novartis UK
PMA0082 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - PHG Foundation
PMA0099 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Mendelian
PMA0094 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Global Alliance for Genomics and Health
PMA0096 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Royal College of Pharmacy
PMA0095 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Health Innovation Wessex and Wessex Cancer Alliance
PMA0115 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - University College London (UCL)
PMA0118 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Blood Cancer UK
PMA0116 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - BCS, The Chartered Institute for IT
PMA0093 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - UCL, UCL, UCL, UCL, UCL, UCL, UCL, and UCL
PMA0092 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - RM Partners
PMA0111 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - PinPoint Data Science
PMA0114 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Centre for Cancer Screening, Prevention and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London
PMA0110 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - iRhythm Technologies
PMA0112 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - NHS Race & Health Observatory
PMA0087 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Alder Hey Children's Charity
PMA0086 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - use MY data
PMA0088 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - University of Southampton, and University of Southampton
PMA0097 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - The EPSRC Causality in Healthcare AI Hub (CHAI)
PMA0098 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Genomics Ltd
PMA0089 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - University of Sheffield
PMA0091 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Sex Matters
PMA0090 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - Cambridge University Health Partners
PMA0103 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 1st June 2026
Written Evidence - University of Cambridge
PMA0104 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Tuesday 2nd June 2026
Formal Minutes - Minutes 1st meeting 19 May 2026

Science and Technology Committee
Tuesday 2nd June 2026
Oral Evidence - Health Data Research Service (HDRS), and Health Data Research Service (HDRS)

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 8th June 2026
Written Evidence - Great Ormond Street Hospital
PMA0120 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee
Monday 8th June 2026
Written Evidence - Kings College London
PMA0119 - Innovation in the NHS: personalised medicine and AI

Innovation in the NHS: Personalised Medicine and AI - Science and Technology Committee